Ss Innovations International, Inc (SSII)
NASDAQ:SSII
Want to see SSII full AI Analyst Report?
SSII Stock Chart & Stats
$6.42
$0.01(0.13%)
At close: 4:00 PM EST
$6.42
$0.01(0.13%)
Day’s Range― - ―
52-Week Range$3.11 - $10.00
Previous CloseN/A
Volume157.00
Average Volume (3M)59.94K
Market Cap
$694.46M
Enterprise Value$645.12M
Total Cash (Recent Filing)$15.98M
Total Debt (Recent Filing)$13.82M
Price to Earnings (P/E)―
Beta9.22
Next Earnings
Aug 06, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding200,131,530
10 Day Avg. Volume56,593
30 Day Avg. Volume59,936
Financial Highlights & Ratios
PEG Ratio2.12
Price to Book (P/B)28.24
Price to Sales (P/S)25.40
P/FCF Ratio-48.61
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue13.32
Enterprise Value/Gross Profit27.52
Enterprise Value/Ebitda-174.01
Forecast
1Y Price Target
$7.00Price Target Upside9.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Margin ExpansionSustained top-line growth and a rising gross margin reflect improving unit economics from system sales and consumables. Better margins reduce the cash needed per incremental sale, supporting a durable path to scale and eventual profitability if revenue momentum continues.
Growing Installed Base And Clinical TractionA rapidly expanding installed base with multi-specialty adoption and an extensive training footprint builds recurring consumable and service revenue. Clinical validation and scale strengthen competitive position and create durable revenue streams across hospitals and regions.
Conservative Leverage / Balance Sheet FlexibilityLow leverage limits interest burden and preserves financial flexibility to fund expansion, regulatory filings and R&D. A conservative capital structure reduces refinancing risk and supports sustained investment in commercialization over the next several quarters.
Bears Say
Negative Operating & Free Cash FlowPersistent negative operating and free cash flow indicate the business consumes cash to scale systems, instruments and service infrastructure. Continued cash burn forces dependence on external financing, constrains reinvestment, and raises execution risk over the medium term.
Senior Finance/operations TurnoverLoss of dual COO/CFO leadership creates continuity risk in operations, financial planning and capital strategy. Recruiting a qualified successor can take months, potentially delaying execution on international rollouts, margin initiatives and financing plans critical to scaling.
ATM Equity Program Increases Dilution RiskAn open ATM facility signals reliance on public equity to fund operations amid cash burn. Future share issuances can dilute existing holders and may be required to sustain growth, making long-term returns sensitive to execution and capital allocation choices.
SS Innovations International News
SSII FAQ
What was Ss Innovations International, Inc’s price range in the past 12 months?
Ss Innovations International, Inc lowest stock price was $3.11 and its highest was $10.00 in the past 12 months.
What is Ss Innovations International, Inc’s market cap?
Ss Innovations International, Inc’s market cap is $694.46M.
When is Ss Innovations International, Inc’s upcoming earnings report date?
Ss Innovations International, Inc’s upcoming earnings report date is Aug 06, 2026 which is in 44 days.
How were Ss Innovations International, Inc’s earnings last quarter?
Ss Innovations International, Inc released its earnings results on May 13, 2026. The company reported -$0.02 earnings per share for the quarter, the consensus estimate of -$0.02 by $0.
Is Ss Innovations International, Inc overvalued?
According to Wall Street analysts Ss Innovations International, Inc’s price is currently Undervalued.
Does Ss Innovations International, Inc pay dividends?
Ss Innovations International, Inc does not currently pay dividends.
What is Ss Innovations International, Inc’s EPS estimate?
Ss Innovations International, Inc’s EPS estimate is -0.01.
How many shares outstanding does Ss Innovations International, Inc have?
Ss Innovations International, Inc has 200,131,530 shares outstanding.
What happened to Ss Innovations International, Inc’s price movement after its last earnings report?
Ss Innovations International, Inc reported an EPS of -$0.02 in its last earnings report, expectations of -$0.02. Following the earnings report the stock price went down -2.92%.
Which hedge fund is a major shareholder of Ss Innovations International, Inc?
Currently, no hedge funds are holding shares in SSII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SS Innovations International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (9.03% Upside)
$7.00 (9.03% Upside)
Blogger Sentiment
Bullish
SSII Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.89%
12-Months-Change
Fundamentals
Return on Equity
-23.00%
Trailing 12-Months
Asset Growth
42.69%
Trailing 12-Months
Company Description
Ss Innovations International, Inc
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.
SSII Stock 12 Month Forecast
Average Price Target
$7.00
▲(9.03% Upside)
Technical Analysis
Conmed
―
Artivion
―
Integra Lifesciences
―
Tandem Diabetes Care
―
Establishment Labs Holdings
―
Ownership Overview
67.67% Insiders
0.46% Mutual Funds
0.71% Other Institutional Investors
31.10% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---